Summary: KQED interviews MAPS Founder Rick Doblin, Ph.D., to discuss the future of psychedelics for a variety of therapeutic uses, focusing on MDMA-assisted psychotherapy for treating veterans and others with chronic, treatment-resistant posttraumatic stress disorder (PTSD). “There should be thousands of psychedelic psychotherapy clinics all over the world,” states Rick Doblin, Ph.D.
Originally appearing here.
In our continuing series “Big Think,” we meet a man who’s researching the use of psychedelic drugs to treat mental illnesses. Rick Doblin leads a Santa Cruz nonprofit that sponsors research using LSD and MDMA to treat treat post-traumatic stress disorder among war veterans. They’re studying how LSD can help ease the dying process for the terminally ill. Reporter: April Dembosky